Biomarkers: How they are enabling precision medicine

Precision medicine is changing the way we think about and treat human disease. By taking into account individual variability at a molecular level, researchers and physicians are able to hone therapies and therapeutic decision making to address the needs of each patient more effectively.  At the heart of this clinical evolution are the biomarkers that researchers and physicians use to identify patient or disease variability that is relevant to choice of therapy.

QuintilesIMS's Winfred Shaw, Senior Director and Head, Precision Medicine Center of Excellence, dives into the four categories of biomarkers utility in his recent blog.

To view the blog and understand more about biomarkers – please click here.

For further content relating to immuno-oncology trials please click here.